Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rafael Giorgetti Frare & Anil Kumar Singh. (2018) A Critical Review of Physicochemical Properties and Analytical Methods Applied to Quantitative Determination of Ebastine. Critical Reviews in Analytical Chemistry 48:2, pages 102-109.
Read now
Read now
S Rico, RM Antonijoan & MJ Barbanoj. (2009) Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines. Journal of Asthma and Allergy 2, pages 73-92.
Read now
Read now
Articles from other publishers (21)
Toan T. Do, Ethan A. Canty & Shyam R. Joshi. (2023) Current and future management of chronic spontaneous urticaria and chronic inducible urticaria. Allergy and Asthma Proceedings 44:1, pages 3-14.
Crossref
Crossref
Prabhakar Priyanka, Bidarur K. Jayanna, Haruvegowda Kiran Kumar, Vinaya, Thayamma R. Divakara, Hemmige S. Yathirajan & Sean Parkin. (2022) Synthesis and crystal structure of ebastinium hydrogen fumarate. Acta Crystallographica Section E Crystallographic Communications 78:9, pages 916-921.
Crossref
Crossref
Maira Ayaz, Fareeha Anwar, Uzma Saleem, Irum Shahzadi, Bashir Ahmad, Ali Mir & Tariq Ismail. (2022) Parkinsonism Attenuation by Antihistamines via Downregulating the Oxidative Stress, Histamine, and Inflammation. ACS Omega 7:17, pages 14772-14783.
Crossref
Crossref
Monisha Gamre, Shyam Khante, Preeti Tamane & Nilesh Desai-Deshmukh. (2022) High-performance thin-layer chromatography (HPTLC) method development and validation for the estimation of curcumin and cineole. JPC – Journal of Planar Chromatography – Modern TLC 35:1, pages 43-50.
Crossref
Crossref
Martin K. Church, Stefan Frischbutter, Pavel Kolkhir & Marcus Maurer. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
515
535
.
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, Lauren Castellana, Kasirajan Ayyanathan, Fabian L. Cardenas-Diaz, Edward E. Morrisey, Rachel Truitt, Wenli Yang, Kellie Jurado, Kirandeep Samby, Holly Ramage, David C. Schultz & Sara Cherry. (2021) Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Reports 35:1, pages 108959.
Crossref
Crossref
Divya Harmalkar, Soraiya Godinho, Prashant Jivaji Bhide, Lalit Kumar & Rupesh Kalidas Shirodkar. (2019) New Formulation Technique for Solubility and Dissolution Rate Enhancement of Poorly Soluble Drugs. Pharmaceutical Chemistry Journal 53:8, pages 720-729.
Crossref
Crossref
Meng Fu, Shuilian Fu, Saihong Ni, Danni Wang & Tie Hong. (2018) Inhibitory effects of bisdemethoxycurcumin on mast cell-mediated allergic diseases. International Immunopharmacology 65, pages 182-189.
Crossref
Crossref
I S Gushchin & I V Danilicheva. (2017) EBASTINE. A REASONABLE CHOICE. Russian Journal of Allergy 14:4-5, pages 89-97.
Crossref
Crossref
Mohammed A. E. Shaibah, Belakavadi K. Sagar, Hemmige S. Yathirajan, S. Madan Kumar & Christopher Glidewell. (2017) Crystal structure of ebastinium 3,5-dinitrobenzoate. Acta Crystallographica Section E Crystallographic Communications 73:10, pages 1513-1516.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
147
221
.
Maulina Sharma, Cathy Bennett, Stuart N Cohen & Ben Carter. (2014) H1-antihistamines for chronic spontaneous urticaria. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Crossref
Sampada A. Shahane, Ruili Huang, David Gerhold, Ulrich Baxa, Christopher P. Austin & Menghang Xia. (2014) Detection of Phospholipidosis Induction: A Cell-Based Assay in High-Throughput and High-Content Format. SLAS Discovery 19:1, pages 66-76.
Crossref
Crossref
Oana I. Stanisor, Sophie A. van Diest, Zhumei Yu, Olaf Welting, Noor Bekkali, Jing Shi, Wouter J. de Jonge, Guy E. Boeckxstaens & Rene M. van den Wijngaard. (2013) Stress-Induced Visceral Hypersensitivity in Maternally Separated Rats Can Be Reversed by Peripherally Restricted Histamine-1-Receptor Antagonists. PLoS ONE 8:6, pages e66884.
Crossref
Crossref
Zhoujie Yu, Wei Wang & Liqin Chen. (2011) Synthesis of [2H5]-ebastine fumarate and [2H5]-hydroxyebastine. Journal of Labelled Compounds and Radiopharmaceuticals 54:7, pages 352-356.
Crossref
Crossref
Ji‐Hong Shon, Chang‐Woo Yeo, Kwang‐Hyeon Liu, Sang‐Seop Lee, In‐Jun Cha & Jae‐Gook Shin. (2013) Itraconazole and Rifampin Alter Significantly the Disposition and Antihistamine Effect of Ebastine and Its Metabolites in Healthy Participants. The Journal of Clinical Pharmacology 50:2, pages 195-204.
Crossref
Crossref
Albert Roger, Josep Fortea, M José Plazas, Sheila Mora & Maite Artés. (2009) Assessment of patient satisfaction with ebastine fast-dissolving tablets in patients suffering from allergic rhinitis. Therapy 6:3, pages 407-415.
Crossref
Crossref
J. Sastre. (2008) Ebastine in allergic rhinitis and chronic idiopathic urticaria. Allergy 63, pages 1-20.
Crossref
Crossref
R. Mösges & J. Köberlein. (2007) Mono- oder Kombinationstherapie mit einem AntihistaminikumNew generation antihistamines as monotherapy or in combination. HNO 55:6, pages 457-464.
Crossref
Crossref
Rosa Antonijoan, Consuelo García-Gea, Montserrat Puntes, Joselin Pérez, Ramón Esbrí, Cristina Serra, Josep Fortea & Manuel J. Barbanoj. (2007) Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. Clinical Therapeutics 29:5, pages 814-822.
Crossref
Crossref
Rosa M Antonijoan, Consuelo Garc??a-Gea, Montserrat Puntes, Marta Valle, Ramon Esbri, Josep Fortea & Manuel J Barbanoj. (2007) A Comparison of Ebastine 10mg Fast-Dissolving Tablet with Oral Desloratadine and Placebo in Inhibiting the Cutaneous Reaction to??Histamine in Healthy Adults. Clinical Drug Investigation 27:7, pages 453-461.
Crossref
Crossref